K2 Therapeutics Names Ying Huang Chief Executive Officer
K2 Therapeutics appointed Ying Huang, Ph.D., as chief executive officer. Huang previously served as chief executive officer and a director of Legend Biotech, where he led the company during commercialization of CARVYKTI with Johnson…
